Find similar content

Source channel @githubtrending · Post #14878 · Jun 28

#cplusplus#arduino#cansat#csv#embedded#graph#ground_station#iot#microcontroller#network#projects#qt#serial#serial_studio Serial Studio is a free, easy-to-use tool that lets you visualize real-time data from devices like microcontrollers via serial ports, Bluetooth, or network connections. It works on Windows, macOS, and Linux, and offers customizable dashboards with various widgets to monitor sensor data, debug info, or telemetry. You can quickly plot data, export it as CSV for analysis, and even use advanced features like checksum validation and JavaScript data processing. It supports hobbyists, educators, and professionals by simplifying data monitoring and debugging, saving you time and effort in understanding your device’s output. Pro versions add commercial use and extra features[1][4][5]. https://github.com/Serial-Studio/Serial-Studio

Hashtags

#cplusplus #arduino #cansat #csv #embedded #graph #ground_station #iot #microcontroller #network #projects #qt #serial #serial_studio

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment